# Lexicon Pharmaceuticals, Inc. (LXRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LXRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 21.79M | $ -32.82M | $ -38.65M | $ 59.28M | $ 174.53M |
| 2025 | $ 50.99M | $ -51.55M | $ -69.47M | $ 62.24M | $ 107.54M |
| 2024 | $ 32.67M | $ -210.64M | $ -189.00M | $ 108.40M | $ 145.95M |
| 2023 | $ 1.30M | $ -191.51M | $ -175.56M | $ 106.06M | $ 93.11M |
| 2022 | $ 155.3K | $ -113.88M | $ -100.74M | $ 55.29M | $ 117.12M |
| 2021 | $ 354.2K | $ -104.31M | $ -104.88M | $ 2.28M | $ 113.60M |
| 2020 | $ 30.57M | $ -74.62M | $ -182.24M | $ 12.81M | $ 156.37M |
| 2019 | $ 415.72M | $ 167.97M | $ 146.81M | $ 246.84M | $ 117.10M |
| 2018 | $ 83.05M | $ -159.90M | $ -196.39M | $ 245.00M | $ -26.41M |
| 2017 | $ 121.69M | $ -173.85M | $ -250.06M | $ 245.67M | $ 52.10M |
| 2016 | $ 114.66M | $ -194.58M | $ -241.95M | $ 101.45M | $ 157.40M |
| 2015 | $ 182.55M | $ -6.57M | $ 258.16M | $ 105.81M | $ 285.85M |
| 2014 | $ 32.29M | $ -141.72M | $ -106.97M | $ 107.67M | $ 284.02M |
| 2013 | $ 3.16M | $ -148.09M | $ -131.98M | $ 21.88M | $ -1.00B |
| 2012 | $ 1.57M | $ -159.12M | $ -137.09M | $ 23.45M | $ 266.68M |
| 2011 | $ 2.72M | $ -170.74M | $ -130.97M | $ 24.89M | $ 297.57M |
| 2010 | $ 7.43M | $ -154.10M | $ -126.43M | $ 28.48M | $ 247.02M |
| 2009 | $ 16.20M | $ -130.59M | $ -135.34M | $ 66.96M | $ 163.79M |
| 2008 | $ 48.94M | $ -123.83M | $ -148.06M | $ 30.49M | $ 185.58M |
| 2007 | $ 75.89M | $ -89.02M | $ -115.41M | $ 31.37M | $ 256.30M |
| 2006 | $ 110.23M | $ -82.23M | $ -91.59M | $ 32.19M | $ 85.50M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.34 |
| Liabilities / Eq | 0.43 |
| Current Ratio | 13.37 |

## Other views

- [Metrics](https://sponda.capital/en/LXRX.md)
- [Charts](https://sponda.capital/en/LXRX/charts.md)
- [Compare](https://sponda.capital/en/LXRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.